Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuhiro Kitamura

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Bioorganic & Medicinal Chemistry Letters|March 10, 2009
Synthesis of actin-depolymerizing compoundsKazuhiro Kitamura, Toshiaki Teruya, Takeshi Kuroda, et al.
Organic Letters|May 13, 2009
Biselyngbyaside, a macrolide glycoside from the marine cyanobacterium Lyngbya spToshiaki Teruya, Hiroaki Sasaki, Kazuhiro Kitamura, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2013
Apoptosis-inducing activity of the actin-depolymerizing agent aplyronine A and its side-chain derivativesOsamu Ohno, Maho Morita, Kazuhiro Kitamura, et al.
European Journal of Pediatrics|April 2, 2008
Estimation of postoperative fat absorption using the 13C mixed-triglyceride breath test in children with choledochal cystMitsuyoshi Suzuki, Kyoko Tanaka, Kiyotaka Ohtani, et al.
International Journal of Clinical Oncology|December 8, 2009
Choroidal metastasis in a patient with small cell lung cancer discovered during treatment with chemotherapyYusuke Okuma, Yukio Hosomi, Kazuhiro Kitamura, et al.
International Journal of Clinical Oncology|February 20, 2009
Retrospective analysis of efficacy and safety of amrubicin in refractory and relapsed small-cell lung cancerTsuneo Shimokawa, Masahiko Shibuya, Kazuhiro Kitamura, et al.
Molecular Cancer Therapeutics|November 22, 2013
MiR-134/487b/655 cluster regulates TGF-β-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cellsKazuhiro Kitamura, Masahiro Seike, Tetsuya Okano, et al.
International Journal of Oncology|July 4, 2012
MiR-23a regulates TGF-β-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cellsMengru Cao, Masahiro Seike, Chie Soeno, et al.
BMC Cancer|April 18, 2015
Control of the MYC-eIF4E axis plus mTOR inhibitor treatment in small cell lung cancerMasaru Matsumoto, Masahiro Seike, Rintaro Noro, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 22, 2011
The feasibility study of Carboplatin plus Etoposide for advanced small cell lung cancer with idiopathic interstitial pneumoniasYuji Minegishi, Hidehiko Kuribayashi, Kazuhiro Kitamura, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry Letters|March 10, 2009
Synthesis of actin-depolymerizing compoundsKazuhiro Kitamura, Toshiaki Teruya, Takeshi Kuroda, et al.
Organic Letters|May 13, 2009
Biselyngbyaside, a macrolide glycoside from the marine cyanobacterium Lyngbya spToshiaki Teruya, Hiroaki Sasaki, Kazuhiro Kitamura, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2013
Apoptosis-inducing activity of the actin-depolymerizing agent aplyronine A and its side-chain derivativesOsamu Ohno, Maho Morita, Kazuhiro Kitamura, et al.
European Journal of Pediatrics|April 2, 2008
Estimation of postoperative fat absorption using the 13C mixed-triglyceride breath test in children with choledochal cystMitsuyoshi Suzuki, Kyoko Tanaka, Kiyotaka Ohtani, et al.
International Journal of Clinical Oncology|December 8, 2009
Choroidal metastasis in a patient with small cell lung cancer discovered during treatment with chemotherapyYusuke Okuma, Yukio Hosomi, Kazuhiro Kitamura, et al.
International Journal of Clinical Oncology|February 20, 2009
Retrospective analysis of efficacy and safety of amrubicin in refractory and relapsed small-cell lung cancerTsuneo Shimokawa, Masahiko Shibuya, Kazuhiro Kitamura, et al.
Molecular Cancer Therapeutics|November 22, 2013
MiR-134/487b/655 cluster regulates TGF-β-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cellsKazuhiro Kitamura, Masahiro Seike, Tetsuya Okano, et al.
International Journal of Oncology|July 4, 2012
MiR-23a regulates TGF-β-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cellsMengru Cao, Masahiro Seike, Chie Soeno, et al.
BMC Cancer|April 18, 2015
Control of the MYC-eIF4E axis plus mTOR inhibitor treatment in small cell lung cancerMasaru Matsumoto, Masahiro Seike, Rintaro Noro, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 22, 2011
The feasibility study of Carboplatin plus Etoposide for advanced small cell lung cancer with idiopathic interstitial pneumoniasYuji Minegishi, Hidehiko Kuribayashi, Kazuhiro Kitamura, et al.
Pageof 2